Associated Papers
Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations.
Kandarpa M et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2024
38386293 (PubMed )
Supplement: ccr-23-0372_supplemental_table_2_suppst2.xlsx › Suppl._Table_2
Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts.
Moura PL et al.
Cancer Research, 2024
37921711 (PubMed )
Supplement: can-23-3038_data_s1_suppsd1.xlsx › Deidentified_clinical_data
The longitudinal dynamics and natural history of clonal haematopoiesis.
Fabre MA et al.
Nature, 2022
35650444 (PubMed )
Supplement: 41586_2022_4785_MOESM12_ESM.xlsx › AML
TET2 missense variants in human neoplasia. A proposal of structural and functional classification.
Bussaglia E et al.
Molecular Genetics & Genomic Medicine, 2019
31187595 (PubMed )
Supplement: MGG3-7-e00772-s003.doc
The cysteine-rich domain of TET2 binds preferentially to mono- and dimethylated histone H3K36.
Yamagata K et al.
Journal of Biochemistry, 2017
TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group.
Gaidzik VI et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2012
22430270 (PubMed )
Supplement: 392886_Gaidzik_DataSupp_revised.pdf
Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies.
Bacher U et al.
Annals of Hematology, 2010
Select a paper to view details